NasdaqCM - Nasdaq Real Time Price USD
Cingulate Inc. (CING)
4.2700
+0.0200
+(0.47%)
As of 11:31:19 AM EDT. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 4 | 3 |
Avg. Estimate | -0.98 | -0.85 | -3.13 | -2.07 |
Low Estimate | -1 | -0.97 | -3.84 | -3.47 |
High Estimate | -0.96 | -0.72 | -2.68 | -0.27 |
Year Ago EPS | -7.2 | -5.47 | -10.2 | -3.13 |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 5 | 4 |
Avg. Estimate | -- | -- | -- | 1.94M |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | 7.77M |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | -12.48 | -4.92 | -2.22 | -1.53 |
EPS Actual | -7.2 | -5.47 | -1.83 | -2.3 |
Difference | 5.28 | -0.55 | 0.39 | -0.77 |
Surprise % | 42.31% | -11.18% | 17.57% | -50.65% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -0.98 | -0.85 | -3.13 | -2.07 |
7 Days Ago | -0.96 | -0.72 | -2.9 | -1.38 |
30 Days Ago | -1.64 | -1.44 | -4.95 | -0.27 |
60 Days Ago | -1.64 | -1.44 | -4.95 | -0.27 |
90 Days Ago | -1.93 | -1.7 | -5.61 | -0.27 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | 1 | -- | 1 | 1 |
Up Last 30 Days | 1 | -- | 1 | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
CING | 86.39% | 84.55% | 69.29% | 33.81% |
S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
Maintains | Ascendiant Capital: Buy to Buy | 4/21/2025 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 3/6/2025 |
Maintains | HC Wainwright & Co.: Buy to Buy | 1/30/2025 |
Initiated | Roth MKM: Buy | 1/10/2025 |
Upgrade | Maxim Group: Hold to Buy | 11/20/2024 |
Maintains | HC Wainwright & Co.: Buy to Buy | 1/5/2024 |
Related Tickers
MRES Institute of Biomedical Research Corp.
0.0165
-8.33%
TOVX Theriva Biologics, Inc.
1.4200
-0.70%
GLYC GlycoMimetics, Inc.
0.2518
+5.46%
NKGN NKGen Biotech, Inc.
0.1229
+0.49%
AZTR Azitra, Inc.
0.2935
-0.51%
TRAW Traws Pharma, Inc.
1.5200
+3.40%
ONCO Onconetix, Inc.
0.0650
-2.55%
ERNA Ernexa Therapeutics Inc.
0.1957
+0.97%
SPRB Spruce Biosciences, Inc.
0.1326
-0.23%
LIPO Lipella Pharmaceuticals Inc.
2.4400
+1.24%